Daiichi Sankyo Co Ltd (4568.T)
22 Mar 2019
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|68||2017||Chairman of the Board, Chief Executive Officer, Representative Director|
|64||2017||Executive President, President, Chief Operating Officer, Representative Director|
|63||2018||Chief Financial Officer, Executive Vice President, Vice President, Chief Director of Business Strategy, Representative Director|
|2018||Managing Executive Officer, Director of Finance & Accounting in Main Business Strategy Unit|
|2016||Senior Managing Executive Officer, Chief Director of Pharmaceutical Sales|
- Japan's Daiichi Sankyo explores OTC drugs business sale, hires JPMorgan -sources
- UPDATE 1-Japan's Daiichi Sankyo explores OTC drugs business sale, hires JPMorgan -sources
- Japan's Daiichi Sankyo exploring sale of OTC business, hires JP Morgan -sources
- BRIEF-Daiichi Sankyo Co, Roche To Collaborate On New HER2 Low Companion Diagnostic Test